8-K: Veradigm Appoints Christian Greyenbuhl as New CFO

Veradigm Inc. announced the appointment of Christian Greyenbuhl as its new Chief Financial Officer, effective May 11, 2026, or later, as the company works to become current with its SEC filings.

Summary

• Veradigm Inc. has appointed Christian Greyenbuhl as its new Chief Financial Officer (CFO).
• The appointment is effective on the later of May 11, 2026, or the first business day after the company files its 2023 and 2024 Annual Reports on Form 10-K.
• Mr. Greyenbuhl will also serve as the principal financial officer and principal accounting officer.
• He replaces Leland Westerfield, who has been serving as Interim CFO.
• Mr. Greyenbuhl brings over 25 years of finance experience, including roles at Ministry Brands, Xplor Technologies, and ADP.
• He has a background in SEC reporting, technical accounting, and capital markets transactions from his time at PricewaterhouseCoopers.
• The company also announced the departure of Tejal Vakharia, Senior Vice President and General Counsel, effective April 30, 2026.
• The Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan was amended to increase the authorized shares by 6,000,000, bringing the total to 17,000,000.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as cautiously optimistic, primarily due to the appointment of a new CFO and the stated commitment to addressing SEC filing obligations. However, the contingent nature of the CFO's start date and the ongoing risks associated with financial reporting delays temper a more positive outlook.

Positives

• Appointment of a new CFO with extensive experience in finance and accounting.
• The new CFO, Christian Greyenbuhl, has a strong background in SEC reporting and capital markets.
• The company is actively working to become current with its SEC filings, as indicated by the CEO's comments.
• The 2024 Stock Incentive Plan has been amended to increase share availability, potentially aiding in future employee retention and motivation.

Negatives

• The effective date of the new CFO's appointment is contingent on the company filing its overdue 2023 and 2024 Annual Reports.
• The company is experiencing executive officer transitions, with the departure of the Senior Vice President and General Counsel.
• The company's common stock is not trading on a national securities exchange and is deregistered from Section 12(b) of the Securities Exchange Act of 1934.
• There is a risk of further material delays in financial reporting and potential identification of additional errors or material weaknesses in internal controls.

Risks

• Further material delay in the company's financial reporting.
• Inability to timely prepare delinquent financial statements.
• Unanticipated factors or factors that currently are believed will not cause further delay.
• Remediation efforts and preparation of financial statements may identify additional errors and material weaknesses.
• Control deficiencies may result in additional material weaknesses in internal control over financial reporting.
• The company's common stock not trading on a national securities exchange and deregistration from Section 12(b) of the Securities Exchange Act of 1934.
• The company's ability to hire qualified individuals to serve in senior leadership roles on a permanent basis.

Future Outlook

The company's strategic initiatives under new leadership are focused on a 'Reset, Recover, Reignite' plan aimed at becoming current with SEC filings, recovering market leadership, and reigniting profitable growth. The appointment of a new CFO is a key step in this process. The company anticipates entering into a consulting agreement with the former Interim CFO to ensure a smooth transition.

Management Comments

• "Our Reset, Recover, Reignite plan is fully launched. Our work to get current and stay current on our SEC filing is progressing. With Christians arrival, the team required to drive our strategic reset, recover our market leadership with independent physician practices, and reignite profitable growth will be largely in place."
• "I am honored to join the Veradigm team at such a pivotal moment. Veradigm has a unique opportunity to leverage its strong market position, differentiated capabilities, and powerful data assets to deliver more actionable insights across the healthcare ecosystem. I look forward to leveraging my accounting and operational strengths to work to ensure that the Company becomes current with its filing obligations and reignites profitable growth."
• "On behalf of myself and the Board of Directors, I want to thank Lee for his tireless service during a time of leadership transition at Veradigm. Lee has led our efforts to get current and stay current on our SEC filings, and the financing that strengthened our liquidity. I look forward to continuing to collaborate with him as we advance key filing milestones."

Industry Context

StockSavvy.ai notes that Veradigm's focus on clinical and revenue cycle solutions for independent practices positions it within the healthcare technology sector, a space increasingly driven by data analytics and AI. The company's efforts to become current with SEC filings and implement a strategic reset are critical for regaining investor confidence and demonstrating operational stability in a competitive market.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Potential positive impact from the appointment of an experienced CFO and the company's stated commitment to becoming current with filings, which could restore confidence. However, ongoing risks related to financial reporting and the company's stock not trading on a national exchange remain concerns.
• Employees: The amendment to the stock incentive plan may provide increased opportunities for equity awards, potentially boosting morale and retention. Executive transitions may create uncertainty.
• Creditors: The company's ability to meet financial reporting obligations is crucial for maintaining trust and potentially securing future financing. The focus on financial stability is a positive indicator.

Next Steps

• Veradigm to file its Annual Reports on Form 10-K for its 2023 and 2024 fiscal years.
• Christian Greyenbuhl's appointment as CFO becomes effective upon the filing of the aforementioned 10-K reports.
• Lee Westerfield will serve in a consulting role to ensure a smooth transition.
• The company anticipates entering into a consulting agreement with Lee Westerfield.
• The Board of Directors will determine performance metrics for Mr. Greyenbuhl's performance stock units.
• The company will continue to work on its 'Reset, Recover, Reignite' strategic plan.

Key Dates

Recommendation

The appointment of a new CFO and the commitment to filing overdue reports are positive steps. However, the contingent start date for the CFO and the significant risks associated with past financial reporting issues and the company's stock trading status warrant a 'hold' recommendation until further clarity and progress are demonstrated.

Keywords

Chief Financial Officer, CFO Appointment, Veradigm Inc., SEC Filings, Financial Reporting, Executive Transition, Stock Incentive Plan, Christian Greyenbuhl